Concentric Qi Li worked overtime to catch up with the goods
Release time:
2021-11-01
This year, Jinhua Pharmaceutical Company won the bid for Tianshili Company to process 60 tons of Chinese medicine yanhusuo decoction pieces. According to the contract requirements, 30 tons of finished products will be delivered to the company's warehouse base in Benxi, Liaoning before 10# June 25 .
According to the production process requirements, Corydalis yanhusuo needs to be broken, bagged and sewn according to the specifications to complete the finished product processing. According to the normal production speed and procedures, it can produce about 3 tons per day, plus subsequent sampling, inspection, production records, preparation of finished product data such as temperature and humidity, and transportation time. Therefore, the pharmaceutical company arranged to start production as planned after the National Day, and the production is expected to be completed in 10 days. However, unfortunately, 10 12 just produced about 10 tons, and received the power restriction notice. 13 , 14 , 20 , 21 , the peak health factory will stop production and have a holiday. If the processing and production of the remaining 20 tons of yanhusuo cannot be completed between 15 and 19 , it will not be delivered on schedule, which will directly affect the company's reputation.
Time is tight and the task is heavy. The management team of the pharmaceutical company immediately organized a meeting of relevant department personnel to adjust the production plan in time. In order not to affect the preparation of subsequent materials, the pharmaceutical company arranged more than 10 people every day from a.m. to p.m. from a.m. to p. m. to work overtime in two shifts, so that the machines did not stop and the personnel changed shifts. The two crushers are started at the same time, handling raw materials, operating the machine to crush, bagging, weighing, sewing bags, and moving bagged pallets into the warehouse. Everyone works together and only takes a rest when the machine is shut down for cooling. As the traditional Chinese medicine processing workshop is located in the Jianfeng Health Factory in Linjiang, and some of the overtime workers are transferred from the pharmaceutical company, the transportation is not very convenient. Therefore, general manager office of the pharmaceutical company specially arranged vehicles to pick up and drop off, which is convenient for employees to go back and forth while further ensuring safety. All overtime workers also gave up their weekend rest time and were all in place on time. After joint efforts, the remaining
20tons of yanhusuo production and processing tasks were finally completed with good quality and quantity before noon on 10 17 . After the relevant staff completed the sampling, inspection, production records, temperature and humidity and other finished product data, they were loaded and sent to Benxi, Liaoning on the morning of 22 , and delivered to the customers on time. (Lei Jun)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page